Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1

Interventions

Early Intervention, Educational 30Educational Status 29Blood Specimen Collection 28Standard of Care 27Methods 25Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Practice Guidelines as Topic 18Surveys and Questionnaires 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Interviews as Topic 11Biopsy 11Specimen Handling 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Breathing Exercises 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × Methylprednisolone Acetate × Clear all
NCT01789892 2018-06-28

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Withdrawn
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡